Burnet + HIV

HIV is a major focus at Burnet, with more than half our work addressing laboratory-based research into finding a cure for the disease while our public health programs are focused on education and prevention both in Australia and overseas.

Nearly 37 million people are living with HIV.

Sub-Saharan Africa is the most affected region with more than 25 million people affected, and accounts for over 65 percent of the global total of new HIV infections. Tragically, HIV claims the lives of 1.1 million people each year globally.

The human immunodeficiency virus (HIV) infects cells of the immune system, causing it to become weak and making it more susceptible to infections. HIV is generally spread through unprotected sexual intercourse or contaminated blood, but can also be spread from mother to child during pregnancy. There is no cure for HIV.

Acquired immunodeficiency syndrome (AIDS) is the most advanced stage of HIV infection. It can take 10-15 years for an HIV-infected person to develop AIDS but antiretroviral (ARV) drugs have made a huge difference in slowing or halting the progression to AIDS.

The World Health Organization (WHO) estimates more than 36 million people are living with the virus, with 2.1 million new infections (of which 20 percent are of adolescent girls and young women aged 15-24) and 1.1 million people dying from AIDS-related illnesses each year. It is estimated that currently only 51 percent of people with HIV know their status. The WHO reports that In 2015, 17 million people living with HIV were receiving antiretroviral therapy (ART) globally, of which 10.3 million were in eastern and southern Africa.

**World AIDS Day - 1 December

World AIDS Day, held each year on 1 December, is an opportunity for people worldwide to show their support for people living with HIV and to commemorate those who have died.

Current Projects

• A novel biomarker for gut leakage as a diagnostic tool for HIV disease progression
  Investigating a novel plasma biomarker's potential for identifying gut leakage.
• Accelerating ART initiation among Infants (AAMI Study)
  This project will trial the POC VISITECT® CD4 test and POC LYNX HIV p24 early infant diagnostic test.
• Access Point Of Care
  Increasing access to life-saving treatments for infectious diseases through point-of-care tests.
• Access to affordable and accurate HIV-1 VL testing
  Laboratory evaluation of a novel filter paper-based method of plasma separation for viral load testing.
• Access to CD4 (VISITECT® CD4) testing among HIV-infected women in Kenya
  An accessible CD4 (VISITECT® CD4) test for HIV-infected pregnant and postpartum women in Kenya.
• ACCESS: STI and BBV surveillance system
  ACCESS is a surveillance system that collates important information on a range of STIs and BBVs.
• APPRISE - Centre for Research Excellence
  The Australian Partnership for Preparedness Research on Infectious Diseases Emergencies (APPRISE).
• Broadly neutralising anti-HIV antibodies and Fc Receptor function
  Defining the properties of anti-HIV antibodies for vaccine development and protection of pregnant women.
• co-EC Study: Eliminating hepatitis C/HIV coinfection
  Eliminating hepatitis C transmission by enhancing care and treatment among HIV co-infected individuals.
• Community-Based Rapid HIV Testing Services
  Evaluating a multi-site rapid HIV testing trial in South Australia and rural site in Bendigo, Victoria.
• CREIDU: Centre for Research Excellence into Injecting Drug Use
  Improving the health of PWID through new research to inform public health policy and practice.
• DARE C: ATAHC II Substudy
  DARE-C aims to evaluate therapy duration using triple therapy (PEG-IFN/RBV/TPV).
• Developing new HIV disease progression tests
  This project will develop prognostic tools to identify HIV+ persons at risk of rapid disease progression.
• Development of a novel prophylactic vaccine candidate for HIV-1
  A prophylactic vaccine represents the best strategy for blocking HIV-1 transmission.
• Enhancing education to reduce harms associated with drug use in Yangon, Myanmar
  This project is supporting harm reduction and health care for people who inject drugs and who use drugs.
• Healthy Mothers, Healthy Babies
  A collaborative research program aimed at providing life-saving health care for women and children in PNG.
• HHISP: Strengthening Papua New Guinea health systems
  Burnet is a partner in the Health and HIV Implementation Services Provider (HHISP).
• HIV Clinical Training for Doctors
  HIV Clinical Training for doctors in urban and rural locations in resource constrained countries.
• HIV Prevention Cohort
  Online cohort study of gay men in Victoria monitoring community-level change.
• HIV testing among young men who have sex with men in Myanmar
  Examining factors associated with HIV testing uptake among young men who have sex with men in Myanmar.
• Intrinsic vaginal factors and their Impact on HIV and other sexually transmitted infections
  This study seeks to determine the impact of vaginal microbiota metabolites on immune mediators and how they influence infection with HIV and other sexually transmitted infections.
• Laboratory Strengthening in Asia Pacific region
  Laboratory tests are needed to guide the use of vital antiretroviral therapy (ART) in HIV infection, however laboratories in developing countries are not ready to perform the sophisticated tests to guide who needs treatment
• Mechanism of action of dendrimer microbicides against HIV
  This study will lead to a greater understanding of how dendrimer nanoparticles can block HIV infection.
• New drugs for HIV prevention: novel inhibitors against an essential HIV target
  The research activity addresses the urgent need for new types of antiviral drugs for preventing HIV transmission.
• Optima decision science
  Research and applications across disease areas to improve allocative efficiency.
• Optima HIV: maximising the impact of HIV funding
  Developing and applying software to maximise the impact of HIV funding around the world.
• PATH Cohort Study
  A cohort study of the trajectories of prisoners with a history of injecting drug use after release from prison.
• Physical activity and HIV
  Non-drug treatments may have important health benefits for people living with chronic illnesses. This project aims to understand the role of physical activity for improving health for those with HIV.
• Plasma separator device for HIV viral load testing
  Aimed at improving access to HIV viral load assays in resource-limited settings.
• Preclinical Clinical Evaluation of Candidate Microbicides
  We are evaluating dendrimer nanoparticles as microbicides to prevent HIV and other sexually transmitted infections.
• PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)
  Burnet is playing a crucial role in monitoring the outcomes of the PrEPX trial in Victoria.
• PRONTO! Rapid HIV point-of-care testing in Victoria
  The first rapid HIV test service in Victoria targeting gay men and men who have sex with men.
• Sex, Drugs, and Rock'n'Roll (Big Day Out Study)
  A landmark study since 2005 of young people's risk behaviours including sex, drug use and alcohol.
• Sexual & Reproductive Health Integration Project (SRHIP)
  SRHIP will expand coverage of STI, HIV, SRH within Catholic and Anglican PNG health services.
• SuperMIX: The Melbourne Injecting Drug User Cohort Study
  A five-year study of the dynamics of cessation of injecting drug use and any subsequent relapse.
• TAIPAN: HIV cascade surveillance
  Internationally novel project to create a linked surveillance system to monitor the HIV cascade for gay men
• Transmitted and acquired drug resistant HIV strains in Victoria, Australia
  This project aims to document the rates and types of mutations associated with drug resistance being acquired by Victorian patients diagnosed with HIV and how this is changing over time.
• Virucidal activity of lactic acid and other carboxylic acids in the vagina against viral STIs
  To understand how lactic acid inactivates HIV and other viral STIs.
• VISITECT® CD4 point-of-care test
  An affordable HIV point-of-care test developed by Burnet but licensed to Omega Diagnostics.
• Working with men to address HIV in Myanmar
  Reducing HIV-related risk, vulnerability and impact among men who have sex with men in Myanmar.

Past Projects

• 2011 Vanuatu Integrated Bio-Behavioural Survey and population size estimation
  A study to estimate the number of men who have sex with men and prevalence of STIs in Port Vila.
• A study to improve the health and rights of Myanmar men who have sex with men
  This research evaluated the effectiveness of ‘Link Up’ services, in men who have sex with men.
• Altered States: An evaluation of VAC drug and alcohol services
  An evaluation of drug and alcohol services at the Victorian AIDS Council targeting GLBTI individuals.
• Call Centre Impact Assessment for Marie Stopes International
  Development of a framework and testing at call centres in Mexico City.
• China-Australia Health and HIV/AIDS Facility (2007-2012)
  A partnership between the governments of Australia and the People’s Republic of China.
• COUNT: Community-based undiagnosed infection and HIV testing study
  Identifying undiagnosed HIV infection among Australian gay men while delivering HIV testing.
• e-TEST: Enhancing STI/HIV testing in high-risk gay men
  eTEST is an intervention and surveillance system that aims to increase STI/HIV testing.
• Evaluation of a condom distribution trial in Victorian prisons
  The evaluation of a pilot program introducing condoms and dental dams into Victorian Prisons.
• Evaluation of the Joint Initiative for Maternal Newborn and Child Health in Myanmar
  Burnet led the evaluation of this United Nations program for maternal newborn and child health.
• FaceSpace: Using social networking to promote safer sex to higher risk groups
  This project aims to use social networking to deliver health messages to higher risk groups.
• Feasibility of antiretroviral treatment monitoring in the era of decentralised HIV care
  A review to assess antiretroviral treatment monitoring in settings of decentralised HIV care.
• Friendly HIV services for young key populations in Bandung, Indonesia
  A pilot project to increase testing and decrease new HIV infections in Bandung.
• Harm reduction among People who Inject Drugs in Myanmar
  Aims to prevent the transmission of HIV among young people, students, migrant and transport workers.
• HIV Cooperation Program for Indonesia (HCPI)
  Government collaboration to improve health outcomes for marginalised populations with HIV infection.
• HIV Prevention Initiatives Evaluation
  An initiative to reduce HIV/STI risk behaviours as well as increasing health seeking behaviours among homosexually active gay men.
• HIV reverse transcriptase structure function and role in HIV replication
  To study the role of reverse transcriptase dimerization in HIV replication.
• HIV services for young key populations in the Philippines
  The Philippines is considering changing laws that require adolescents to seek parental consent for HIV testing. This project will explore options and contribute to better understanding of how new laws might result in improved practices.
• HIV-associated neuropathy (HIV-SN): epidemiology and genetics
  HIV-associated neuropathy (HIV-SN) is a very common cause of pain in the lower limbs for people with HIV. Understanding which patients are at risk will assist preventing and treating this disabling condition.
• HIV/AIDS Passive Surveillance
  Carries out surveillance for HIV and AIDS in Victoria.
• MicroCube Technology Vaccine Platform – collaboration with Monash University
  Burnet and Monash University are examining how the protein crystals excreted by insects after a virus could help create new vaccines to protect people against diseases like HIV.
• Opportunities to improve the health of behaviourally bisexual men in Vientiane, Laos
  Men with bisexual behaviour in Laos engage in high-risk behaviours with low access to sexual health care.
• Performance of a low-cost, rapid point-of-care CD4 test in resource-constrained settings
  This simple test could help prevent delayed initiation of antiretroviral interventions.
• Reducing Community Vulnerability to HIV/AIDS (RCVHA), 2004-2010
  APAC program
• Resources for improving national responses to HIV and STIs
  These resources aim to build country leadership of more effective responses to the HIV and STI epidemics.
• Risk assessment of drug users in Dar es Salaam, Tanzania
  This consultancy accessed the results of a rapid assessment and response of people who use drugs in Tanzania.
• Scaling Up of Most at Risk Populations Component II (SUM II)
  Over five years, this project aims to improve the performance of Indonesian civil society organisations (CSOs) in servicing those in the population that are most at risk of HIV and AIDS
• Socioeconomic impact of HIV at household level in Myanmar
  This study sought to gain a deeper understanding of the socioeconomic impact of HIV in Myanmar by looking at individual and community groups.
• Strengthening Sexual and Reproductive Health Capacity in Bali
  This project is aimed at building capacity around Sexual and Reproductive Health (SRH) and strengthening links between SRH and HIV prevention care and support
• Suck it And See....
  A study to define the rates of HIV amongst gay men in Victoria and to better understand the spread of HIV.
• The Victorian Primary Care Network for Sentinel Surveillance on BBVs and STIs
  The surveillance involves collection and linking of testing, demographic, and risk behaviour information.
• USAID’s AKSI Stop AIDS Project
  Implemented by Family Health International, Burnet was contracted to support activities in a number of harm reduction areas including situational assessment, training, program design and implementation and advocacy
• Victorian Pre-exposure Prophylaxis (PrEP) Demonstrations
  This prevention strategy involves people who are HIV-negative taking HIV treatment medications to reduce their risk of acquiring HIV.